Stay updated on Safety Tolerability WVE-120102 in Huntington's Disease Clinical Trial

Sign up to get notified when there's something new on the Safety Tolerability WVE-120102 in Huntington's Disease Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Safety Tolerability WVE-120102 in Huntington's Disease Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    A new site revision (v3.4.2) is added and the earlier funding notice (v3.4.1) is removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2026-02-11T14:17:17.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    Added a notice about the lapse in government funding and NIH Clinical Center status with a link for updates. Updated the page revision to v3.4.1, replacing v3.4.0.
    Difference
    0.3%
    Check dated 2026-02-04T10:30:51.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    The page now shows a glossary and updates metadata with 'Last Update Submitted that Met QC Criteria' and 'Revision: v3.4.0', while the older variants 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4' were removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-28T06:13:24.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    Revision: v3.3.4 is now shown on the page, replacing v3.3.3. This is a metadata/template update and does not change study details, eligibility criteria, locations, or outcomes.
    Difference
    0.0%
    Check dated 2026-01-14T03:40:35.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    Expanded study locations across the US (California, Massachusetts, Ohio, Tennessee), Australia (New South Wales, Queensland, Victoria, Western Australia), Canada (Alberta, Ontario, Quebec), and other regions. The HHS Vulnerability Disclosure link was removed and the page revision updated to v3.3.3.
    Difference
    1%
    Check dated 2025-12-23T21:27:05.000Z thumbnail image
  7. Check
    91 days ago
    Change Detected
    Summary
    Publications section now states entries are automatically populated from PubMed and may not pertain to the study. Revision: version updated from v3.2.0 to v3.3.2.
    Difference
    0.1%
    Check dated 2025-11-25T10:18:15.000Z thumbnail image

Stay in the know with updates to Safety Tolerability WVE-120102 in Huntington's Disease Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Safety Tolerability WVE-120102 in Huntington's Disease Clinical Trial page.